The U.S. Department of Energy (DOE) today announced $22 million in funding for nine projects covering a range of energy research topics from grid integration, solar energy, wind energy, and advanced manufacturing.
DHS S&T successfully tested four prototype technologies for early detection of wildfires in California this week.
ECS is proud to announce that the 240th ECS Meeting will take place at the Orange County Convention Center in Orlando, FL, from October 10-14, 2021. The Electrochemistry in Space Symposium is a highlight of the meeting, among other events. Learn more!
Obamacare will get retooled, not repealed. A national mask mandate will boost consumer spending, research shows (though don’t expect much from homeowners, they’re strapped). The $300 billion for R&D should go to D, not R. So forecasts an array of WashU experts.
Each corn harvest leaves behind leaves, husks and cobs. Research shows cattle can take advantage of this food resource without damaging field productivity.
Texas Biomedical Research Institute (Texas Biomed) in San Antonio, Texas, was awarded $1 million from the Bill & Melinda Gates Foundation to test the efficacy of human monoclonal antibodies (MAbs) for the treatment of SARS-CoV-2 infection. MAbs are human-made proteins meant to mimic human immune system antibodies. Texas Biomed Professors Luis Martinez-Sobrido, Ph.D. and Jordi B. Torrelles, Ph.D. will co-lead the project to evaluate the protective efficacy of these MAbs in small rodent models, developed at Texas Biomed, on behalf of the Coronavirus Immunotherapy Consortium (CoVIC), an international nonprofit consortium evaluating MAb therapeutics for COVID-19.
Baylor Scott & White Health, the largest not-for-profit health system in the state of Texas, today announces two separate academic affiliations: a new affiliation with Baylor College of Medicine and an expanded affiliation with their long-time partner Texas A&M University. Both alliances are aimed at training future clinicians and developing programs that advance high-quality care and healthcare innovation.
Earlier this month, Baylor Scott & White Research Institute enrolled the first four patients in the world on Gilead’s new clinical trial involving an investigational inhaled solution of remdesivir (NCT04539262). This is Gilead’s first trial in COVID-19 patients examining the safety and efficacy of an inhaled solution of the drug in an outpatient setting. The study of an inhaled solution asks whether this mode of delivery can help reduce the amount of virus from the airways earlier.
The University of Chicago Medicine is launching a clinical trial to examine the potential of an antibody against the SARS-CoV-2 spike protein for treating COVID-19, the disease caused by the novel coronavirus.
The Israel – U.S. Binational Industrial Research and Development (BIRD) Foundation announced it is seeking proposals for collaborative projects to develop advanced technologies for the homeland security mission.
Researchers have developed a technology called “Artificial Chemist,” which incorporates artificial intelligence and an automated system for performing chemical reactions to accelerate R&D and manufacturing of commercially desirable materials.
Men who tested positive for COVID-19 are now being enrolled in a unique study led by the University of Miami Miller School of Medicine to determine the interaction of the virus with semen.
This release concerns conclusive results from a research project that was put together to model the potential spread of coronavirus through air particles in indoor public spaces such as supermarkets (https://www.aalto.fi/en/news/researchers-modelling-the-spread-of-the-coronavirus-emphasise-the-importance-of-avoiding-busy)
For COVID-19 patients in severe respiratory distress, the University of Miami Miller School of Medicine now offers access to mesenchymal stem cell (MSC) treatments that may help fight the characteristic inflammation that accompanies the viral infection. On April 5, the…
An announcement that the Harrington Discovery Institute at University Hospitals is accepting letters of intent for the 2021 Harrington Scholar-Innovator Award. The award offers inventive physician-scientists resources and expertise to advance their discoveries into medicines.
DHS S&T SVIP is looking for start-ups to develop or adapt a system to more clearly mark and track objects in the water.
Imperial College London researchers have invented a new health tracking sensor for pets and people that monitors vital signs through fur or clothing.
The Association for Research in Vision and Ophthalmology (ARVO) today announced the launch of a new career development program aimed to provide early-career underrepresented minority (URM) scientists the opportunity to explore novel and innovative ideas through a two-year $100,000 grant.
MITRE Announces New VP of Public Sector Programs
Florida International University and MITRE, a not-for-profit corporation dedicated to research and development in the public interest, have entered into a strategic partnership to work on the most significant challenges facing the nation. The partnership will involve joint efforts to promote innovation to benefit the government and the public; enhance economic development in South Florida; and enhance FIU student talent development and preparation in key areas driving 21st century innovation and job creation.
The United States leads the world in innovation, research, and technology development. Since World War II, the new markets, industries, companies, and military capabilities that emerged from the country’s science and technology commitment have combined to make the United States the most secure and economically prosperous nation on earth.
DHS S&T awarded QED Secure Solutions of Coppell, Texas, $200,000 to field test a secure trust anchor for the Internet of Things (IoT) as part of S&T’s Silicon Valley Innovation Program (SVIP).